Evidence map›Paper›PMID 37337303›Full record

ArticlePediatric blood & cancer2023

Family perspectives on the transition from active treatment to survivorship for children with cancer.

Kellee Parker, Vivian Christensen, Susan Lindemulder, Lai Hin Kimi Chan, Lauren Saxton, Erika Cottrell

Open access · greenAbstract read
In one paragraph

Article in Pediatric blood & cancer, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
4.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Kellee ParkerDivision of Pediatric Hematology and Oncology, Department of Pediatrics, University of Utah, Salt Lake City, Utah, USA.
Vivian ChristensenOregon Clinical and Translational Research Institute, Oregon Health and Science University, Portland, Oregon, USA.
Susan LindemulderDivision of Pediatric Hematology and Oncology, Department of Pediatrics, Oregon Health and Science University, Portland, Oregon, USA.
Lai Hin Kimi ChanDepartment of Family Medicine, University of California Davis, Sacramento, California, USA.
Lauren SaxtonOregon Clinical and Translational Research Institute, Oregon Health and Science University, Portland, Oregon, USA.
Erika CottrellOregon Clinical and Translational Research Institute, Oregon Health and Science University, Portland, Oregon, USA.
Oregon Clinic · USOregon Health & Science University · USUniversity of California, Davis · USUniversity of Utah · US

Funding

Oregon Clinical and Translational Research Institute - The National COVID Cohort Collaborative (N3C)UL1TR002369 · NCATS · OREGON HEALTH & SCIENCE UNIVERSITY · PI Cynthia D Morris, Christopher G. Slatore · 2017 to 2026
$78.4M
Oregon Clinical and Translational Research Institute TL1 ProgramTL1TR002371 · NCATS · OREGON HEALTH & SCIENCE UNIVERSITY · PI ALLISON Deborah FRYER, JESSINA C MCGREGOR · 2017 to 2026
$6.2M
NCATS NIH HHS TL1 TR002371NCATS NIH HHS UL1 TR002369
6 · The paper itself

Abstract

backgroundCompleting therapy for childhood cancer is an exciting milestone. However, this adjustment can be extremely stressful for patients and their families as they transition from cancer patient to survivor. A better understanding of the patient and family experience and their needs during this transition is crucial for developing guidelines and leveraging support for future patients and families. PROCEDURE: Participants were recruited from across the United States using a maximum variation sampling strategy. Families were eligible if they had a child diagnosed with cancer before age 15 and had completed treatment at least 1 year prior to their interview. Participants completed a 90-180-minute semi-structured interview either in person or virtually. Interviews focused on the experiences of getting a diagnosis, experiences with treatment, information seeking, impact of cancer on the family, social support, and transitions to survivorship. Inductive thematic analysis revealed a wide variety of themes. This paper examines the transition from active cancer therapy into survivorship.

resultsIdentified primary themes included (i) feelings about transitioning off therapy; (ii) coping with lingering effects; and (iii) experiences of transitioning off therapy and survivorship care. Subthemes highlighted the need for more support for both patients and families during this transition.

conclusionPatients and families desire more support during the transition off therapy. Suggestions included access to additional resources, earlier transition to receiving survivorship care, and more holistic survivorship care. Further research is needed to determine best models and feasibility of delivering this desired support to all patients and families.

Indexed as

NeoplasmsSurvivorshipAdaptation, PsychologicalAdolescentChildHumansQualitative ResearchSocial SupportSurvivorsfamily perspectivespediatric cancersupportsurvivorshiptransition

Identifiers

PMID37337303
PMCPMC10527349
OpenAlexW4381309047

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.